Meeting of the Oncologic Drugs Advisory Committee (ODAC)

Using MRD to accelerate drug approval in multiple myelomaSee more

MRD as an endpoint for accelerating drug approval in multiple myeloma: updates from the ODAC meetingSee more

November 16, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)See more

Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in EuropeSee more

Disappointing Sotorasib Results: How to Move ForwardSee more

Oncologic Drugs Advisory Committee MeetingSee more

Conversations on Cancer: ODAC Chronicles - Past, Present, & Future of Oncology Advisory CommitteesSee more

June 16, 2023 Meeting of the pedsODACSee more

March 15, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)See more

March 5, 2024 Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC)See more

May 19, 2023 Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC)See more

September 22-23, 2022 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - Day 1See more

Clinical implications of the ODAC vote in favor of polatuzumab vedotin for untreated DLBCL.See more

September 22-23, 2022 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - Day 2See more

October 28, 2022 Meeting of the Oncologic Drugs Advisory Committee (ODAC)See more

April 28, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)See more

March 9, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)See more

February 9, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)See more

Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (pedsODAC) - Day 2See more

November 9, 2022 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)See more